1.Application of the word Bentai in acupuncture and moxibustion.
Chinese Acupuncture & Moxibustion 2015;35(11):1192-1193
By retrieval and analysis of literature, the origin and connotation of the word Bentai were stated. In the early twentieth century, one Japanese scholar introduced the word into acupuncture-moxibustion. It was mostly used to explore the mechanism of acupuncture-moxibustion and acupoints through scientific research. One Chinese scholar introduced the connotation into acupuncture and moxibustion in 1940, and it was mainly expressed the essence. Professor ZHU Bing systematically discussed Bentai of acupoints from a scientific point of view. The knowledge of acupoints, however, is diverse, and there is different cognition due to multiple perspectives. Acupoints may not have unique Bentai.
Acupuncture Points
;
Acupuncture Therapy
;
history
;
History, 20th Century
;
History, 21st Century
;
Humans
;
Moxibustion
;
history
;
Terminology as Topic
2.Inhibition of survivin expression by RNA interference in renal cancer cell line 786-O
Journal of Chongqing Medical University 2007;0(09):-
Objective:To study the inhibition of survivin expression by small interference RNA(siRNA) synthesized in vitro in renal cancer cell line 786-O. Methods:Three groups of survivin siRNAs were chemically synthesized in vitro and then transfected into cell line 786-O. The expression of survivin mRNA and protein after transfection were detected by reverse transcription polymerase chain reaction(RT-PCR)and Western Blotting. The proliferation of cells was detected by MTT. Results:Two sequence specific siRNAs targeting survivin down-regulated the expression of survivn mRNA and protein. The proliferation of cells was inhibited after transfection. The third one was ineffective. Conclusion:Sequence specific siRNA targeting survivin can efficiently inhibit the survivin expression and cell proliferation in renal cancer cell line 786-O. The successful application of RNAi targeting survivin might extend the list of available gene therapeutic modalities in renal cancer.
5.Analysis of 23 cases with esophageal stricture treated with esophageal stenting
Chinese Journal of Primary Medicine and Pharmacy 2010;17(11):1462-1463
Objective To observe the effects of esophageal stricture treated with esophageal stenting.Methods 23 esophagus stenosis patients were expanded to 1 lmm,and the stent was implanted-.Results 23 patients were set into successfully,7 cases could enter the common food,11 caces could enter the soft food,5 cases could enter the semiliquid food.18 cases had the ache,6 cases had the stomach esophagus regurgitation symptom.During 1?12 month follow-up,10 cases survived,13 cases died,the cause of death was mainly later period cancer failure and metastasis.Conclusion Esophagus stenosis treatment operation was simple,safe,and the wound small,the short-term curative effect would be good.
6.Study of small intestinal bacteria overgrowth in patients with minimal hepatic encephalopathy
Chinese Journal of Postgraduates of Medicine 2010;33(34):3-5
Objective To investigate the prevalence of small intestinal bacteria overgrowth (SIBO)in patients with minimal hepatic encephalopathy (MHE). Methods Ninety patients with cirrhosis and 20 healthy volunteers were studied. All of them were assessed with glucose hydrogen breath test (GHBT) to detect SIBO. And number connection test (NCT-A, NCT-BC) and digit symbol test (DST) were used to diagnose MHE. Results One case (5.0%) out of 20 healthy volunteers was SIBO and none was MHE,and 28 cases (31.1%) out of 90 cirrhosis patients were SIBO and 38 cases (42.2%) were MHE. Twenty-one (55.3%,21/38) cases were diagnosed as SIBO among these patients with MHE,and 7 cases (13.5%,7/52)were diagnosed as SIBO among these patients without MHE. There was significant difference between cirrhosis with MHE and cirrhosis without MHE (x2 = 17.90,P< 0.01 ). Conclusions Patients with cirrhosis have a higher prevalence of SIBO. The incidence rate of SIBO in cirrhosis patients with MHE is more than that without MHE.
7.Effect of venlafaxine sustained-release tablet combined with Shuganjieyu capsule in the treatment of post-stroke depression
Chinese Journal of Primary Medicine and Pharmacy 2013;20(20):3074-3076
Objective To compare the effect and safety of venlafaxine sustained-release tablet combined with Shuganjieyu capsule and venlafaxine sustained-release tablet used singlely in the treatment of moderate to severe poststroke depression.Methods 70 patients suffered from moderate to severe post-stroke depression were randomly divided into two groups,35 cases in each group.The patients in the control group were only treated with venlafaxine sustained-release tablet,and the patients in the study group were treated by venlafaxine sustained-release tablet combined with Shuganjieyu capsule.The treatment lasted 6 weeks.The therapeutic effect and safety were evaluated by the positive and negative syndrome scale of HAMD (17 items),and treatment emergent symptom scale of TESS.Results After treatment for 6 weeks,the total effective rate of the study group was 88.57%,which was significantly higher than 65.71% of the control group (x2 =5.19,P < 0.05).The HAM D score of the study group w.as (16.42 ± 6.07) points,and the HAMD score of the control group was(10.54 ± 5.23) points after 6 weeks.The difference was statistically significant between the two groups (t =4.34,P < 0.01).The difference of TESS score between two groups was not significant(t =0.18,P > 0.05).Conclusion Venlafaxine sustained-release tablet combined with Shuganjieyu capsule is effective and safe in the treatment of moderate to severe post-stroke depression.
8.Heparanase and atherosclerosis
International Journal of Cerebrovascular Diseases 2013;21(8):634-637
Heparanase (HPA) is a β-D-endoglycosidase of the only degradation of heparan sulfate proteoglycans in extracellular matrix in mammals.The related studies in recent years have suggested that HPA is closely associated with the formation and development of atherosclerotic plaques,and may be associated with the conversion from stable to unstable plaques.This article reviews the related studies of HPA in atherosclerosis progression,such as promoting plaque inflammatory response,synergy with proteolytic enzymes,and involving in hypercoagulable states,etc.
9.Protective effects of ziprasidone on the damage of hippocampal-derived neural stem cell induced by lipopolysaccharide
Chinese Journal of Behavioral Medicine and Brain Science 2014;23(2):118-121
Objective To investigate the effects of ziprasidone on the hippocampal-derived neural stem cells (NSCs) viability and apoptosis injured.by LPS.Methods The NSCs were derived from the hippocampus of fetal rats,after the primary neurospheres passaged,the cells were treated with LPS (200 μg/L) and different concentrations of ziprasidone for 48 h or 72 h.The cell viability and the level of LDH were measured by the kit of WST-8 and LDH detected kit,respectively.Furthermore,the apoptosis rate of each dosage group was measured by using Annexin-V-FLUOS Staining Kit.Results (1) Cell viability test showed that the cell viability of LPS group (OD value,0.265± 0.047) was significantly reduced than that of sham (OD value,0.380± 0.029),LPS + 5 μM (OD value,0.316±0.008) and LPS+10 μM (OD value,0.321±0.006) group after ziprasidone treatment for 48 h.There were also significant difference of cell viability between sham,LPS+5 μM,LPS+ 10 μM and LPS group after ziprasidone treatment for 72 h.(2) LDH test showed that the LDH level of LPS group was significantly decreased than that of sham,LPS+5 μM and LPS+10 μM after 48 hour's ziprasidone treatment (P<0.01).The LDH level of LPS group was also significantly reduced than that of sham,LPS+5 μM and LPS+10 μM after 72 hour's ziprasidone treatment (P< 0.01).(3) The apoptosis of LPS + 10 μM ((17.87 ± 2.29) %),LPS + 5 μM ((18.45 ± 3.84) %) treated group or sham group ((9.15 ± 1.54) %) was significantly lower than LPS group ((22.67 ± 2.15)%) by using flow cytometry after 48 h treatment.Furthermore,the apoptosis of LPS+ 10 μM ((10.52± 1.42)%) treated group or sham group((8.45±1.04)%) was significantly lower than LPS group((15.70± 2.97) %) after 72 h treatment.Conclusion The cellular damage of NSCs injured by LPS can be restrained by ziprasidone,and this effect might be one of the cellular mechanism of neural protective effect of ziprasidone.
10.The cognition impairment of Parkinson's disease subtypes and risk factors for cognitive dysfunction
Chinese Journal of Geriatrics 2015;34(3):256-259
Objective To explore the cognition impairment of Parkinson's disease (PD) subtypes and the risk factors for cognitive dysfunction.Methods Totally56 patients with PD and 30 control subjects were selected.All patients were assessed by Mini-Mental State Examination (MMSE),the Montreal cognitive assessment scale (MoCA),digital span test scale (DS),block design test scale (BD).The cognition impairment status of PD subtype was compared between the two groups.Risk factors for cognitive impairment in Parkinson's disease were analyzed by the multiple regression analysis.Results The scores (or accuracy) of visuospatial / executive function,memory,repeat,attention,animal naming,understanding,calculation,orientation in PD patients and control group were (29.84±13.78) and (44.63±10.95),(17.64±3.00) and (21.93±2.12),(1.64±0.90) and (2.40±0.62),64.29% and 86.67%,(2.25±0.77) and (2.70±0.47),(2.66± 0.67) and (2.93±0.25),(3.98±1.17) and (4.93±0.25),(9.59±0.68) and (9.93±0.25) respectively,and there were statistically significant differences in above indictors between two groups (t=-5.080,-7.707,-4.571,-3.374,-2.710,-5.844,-3.367,respectively,x2 =4.86,all P<0.05).Pearson correlation analysis showed that the cognitive function had a positive correlation with education status,had negative correlations with duration of disease,Unified Parkinson's Disease Rating Scale (UPDRS)-Ⅲ,Hoehn and Yahr (H-Y) staging,Hamilton Anxiety Scale (HAMA),Hamilton Rating Scale for Depression (HRSD) (MMSE:r=0.488,-0.682,-0.478,-0.465,-0.611,-0.538,respectively,all P<0.05,MoCA:r=0.553,-0.583,-0.396,-0.384,0.499,-0.444,respectively,all P<0.05),and had no correlation with gender,age,age of onset.Taking the duration of disease,education status,UPDRS-Ⅲ,H-Y grade,HAMA,HRSD as the independent variable,MMSE,MoCA as the dependent variable,multiple linear regression analysis showed that only the duration of disease and education status had effects on cognitive dysfunction in PD (MMSE:β=-0.042,0.196,both P=0.000,MoCA:β=-0.052,0.367,both P<0.05).Conclusions The key points of cognition impairment in PD patients are the impairments in visuospatial/ executive function,memory,repeat,attention,animal naming,understanding,calculation and orientation.The duration of disease and low level of education are the risk factors for cognitive dysfunction in patients with Parkinson's disease.